Literature DB >> 6500626

Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits.

F Goto, S Nakamura, K Goto, M Yoshinaga.   

Abstract

Highly pure polymorphonuclear leucocytes (PMN) were prepared from peritoneal exudate cells which were induced by an i.p. injection of casein into C3H mice and rabbits. The PMN were tested for the production of a lymphocyte proliferation potentiating factor with various stimulations in vitro. In both animal species, the purified PMN from the inflammatory site 3 hr after injection (3-hr PMN) produced the factor upon stimulation with kaolin, while the purified PMN from the lesion 24 hr after injection (24-hr PMN) did not. The 3-hr PMN produced the potentiating factor during a relatively earlier period after in vitro stimulation with kaolin. Protein synthesis inhibitors did not inhibit the factor production, suggesting the release of a preformed factor from 3-hr PMN. The effect of kaolin did not appear to be simply due to its cytotoxicity, because the release was dependent on the metabolism of 3-hr PMN and not parallel with 51Cr-release from the PMN. The factor produced by mouse PMN had an MW of about 15,000-25,000; it consisted of two isoelectrophoretically distinct factors, i.e. pI 9.4 and 5.4. The rabbit PMN factor was slightly smaller (MW ranging between 10,000 and 20,000) than the mouse PMN factor and was composed of three pI species, i.e. 7.2, 5.4, and 4.5.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500626      PMCID: PMC1454885     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Interaction between lymphocytes and inflammatory exudate cells. I. Enhacement of thymocyte response to PHA by product(s) of polymorphonuclear leukocytes and macrophages.

Authors:  M Yoshinaga; S Nakamura; H Hayashi
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

2.  Synthesis and secretion of a mitogenic protein by macrophages: description of a superinduction phenomenon.

Authors:  E R Unanue; J M Kíely
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Purification and properties of human lymphocyte activating factor (LAF).

Authors:  G Blyden; R E Handschumacher
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

4.  Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.

Authors:  P A Murphy; P L Simon; W F Willoughby
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

5.  A PMN-derived factor that enhances DNA-synthesis in PHA or antigen-stimulated lymphocytes.

Authors:  M Yoshinaga; K Nishime; S Nakamura; F Goto
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

6.  The in vivo quantitation and kinetics of rabbit neutrophil leukocyte accumulation in the skin in response to chemotactic agents and Escherichia coli.

Authors:  A C Issekutz; H Z Movat
Journal:  Lab Invest       Date:  1980-03       Impact factor: 5.662

7.  The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis.

Authors:  J Calderon; J M Kiely; J L Lefko; E R Unanue
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

8.  Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen.

Authors:  L J Rosenwasser; C A Dinarello; A S Rosenthal
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

9.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  7 in total

1.  Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides.

Authors:  C Jupin; M Parant; L Chedid; C Damais
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

2.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Immunomodulation in mineral dust-exposed lungs: stimulatory effect and interleukin-1 release by neutrophils from quartz-elicited alveolitis.

Authors:  Y Kusaka; R T Cullen; K Donaldson
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease.

Authors:  Y Niwa; Y Mizushima
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

5.  Crystal-neutrophil interactions lead to interleukin-1 synthesis.

Authors:  C J Roberge; J Grassi; R De Médicis; Y Frobert; A Lussier; P H Naccache; P E Poubelle
Journal:  Agents Actions       Date:  1991-09

6.  Age-dependent basal level and induction capacity of copper-zinc and manganese superoxide dismutase and other scavenging enzyme activities in leukocytes from young and elderly adults.

Authors:  Y Niwa; O Iizawa; K Ishimoto; H Akamatsu; T Kanoh
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).

Authors:  A Araki; T Inoue; S Kimura; S Fukase; F Sendo
Journal:  Jpn J Cancer Res       Date:  1990-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.